Session date: 
10/31/2024 - 7:30am to 11/21/2024 - 8:30am

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Recognize challenges associated with long term management of disseminated histoplasmosis
  • Identify specific adverse reaction related to different azoles
  • Interpret laboratory diagnostics for monitoring of disseminated histoplasmosis
  • Assess risk of disseminated histoplasmosis associated with biologic immunosuppression

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
Jack Mc Hugh, MB, B, Ch., BAO
Co-presenter: 
Portia Mira, PhD
Additional presenter: 
Abbie Blunier, Pharm.D.
Support location: 
Minnesota

Please login or register to take this course.
Support location: 
Minnesota